Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2006
11/08/2006EP1718613A1 Pyridine derivatives and their use as cb2 receptor modulators
11/08/2006EP1718609A1 Substituted azetidine compounds, their preparation and use as medicaments
11/08/2006EP1718608A1 Viral polymerase inhibitors
11/08/2006EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006EP1539742B1 Indole derivatives useful as histamine h3 antagonists
11/08/2006EP1429761B1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
11/08/2006EP1080074B1 Heterocyclic substituted amides, their production and their use
11/08/2006CN1860624A Material and cell structure for memory applications
11/08/2006CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors
11/08/2006CN1860097A Amide type carboxamide derivative
11/08/2006CN1859912A Inhibitors of Akt activity
11/08/2006CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006CN1283635C Heterocyclic retinoid compounds
11/07/2006US7132568 beta-amino amides; treating degenerative dementias characterized by beta-amyloid deposits in the brain, especially Alzheimer's Disease
11/07/2006US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006US7132440 such as 2-[4-(2-Phenyl-[1,3]dioxolan-2-yl)-phenyl]-1H-benzoimidazole-5-carboxylic acid amide; for treatment of cancer
11/07/2006US7132438 Benzimidazole derivatives
11/07/2006US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006US7132435 Syn-1H-indazole-3-carboxylic acid (4-{[2-(2,3-dihydro-benzo[b]thiophen-6-yloxy)-5-fluoro-pyridine-3-carbonyl]amino}-cyclohexyl)-amide; useful as cyclic nucleotide phosphodiesterase-4 ( PDE-4 ) inhibitor
11/07/2006US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006US7132414 Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
11/07/2006CA2274093C Substituted pyrimidinone and pyridinone compounds and their use
11/07/2006CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006WO2006116158A1 Benzodioxane and benzodioxolane derivatives and uses thereof
11/02/2006WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006WO2006114220A1 Herbicidally active phenylsulphonyl-urea
11/02/2006WO2006093823A9 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis
11/02/2006WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006US20060247439 Mchir antagonists
11/02/2006US20060247302 Novel compounds, pharmaceutical compositions containing same, and methods of use for same
11/02/2006US20060247280 Non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, useful in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis; 3-Benzyl-5-(benzylthio)-1,2,4-triazole
11/02/2006US20060247276 Benzofuranyl alkanamine derivatives and uses thereof
11/02/2006US20060247275 Treating hyperproliferative disorders such as gastrointestinal cancer, breast cancer, head cancer, or neck cancer; N-(4-trifluoromethoxyphenyl) 3-[(quinolin-4-ylmethyl)amino]thiophene-2-carboxamide
11/02/2006US20060247274 N,N-bis(3-Phenoxycinnamyl)Glu(O-t-Bu)-OMe; demonstrate competitive binding with the natural ligand; ease administration, cost less and facilitate patient compliance; USEFUL IN TREATMENT OF DISEASES OR CONDITIONS ASSOCIATED WITH ERYTHROPOIETIN RECEPTOR
11/02/2006US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006US20060247249 Carboximide derivatives as useful uro-selective alpha-1a adrenoceptor blockers
11/02/2006US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006US20060247242 Pesticidal compositions
11/02/2006US20060247240 Method of treatment and/or prevention of brain, spinal or nerve injury
11/02/2006US20060247238 5-Chloro-thiophene-2-carboxylic acid ((3S ,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide; anticoagulant, inhibit coagulation factor Xa
11/02/2006US20060247225 e.g. (1 alpha ,5 alpha ,6 alpha )-N-[3-(4-methyl-3-pentenyl)-3-azabicyclo[3.1.0]hex-6-yl]-2-hydroxy-2-cyclopentyl-2-(4-methoxy)phenylacetamide; respiratory, urinary and gastrointestinal systems disorder; antidiabetic agent
11/02/2006US20060247224 Melanocortin receptor ligands
11/02/2006EP1717232A1 Phenylsulfonylureas with herbicidal activity
11/02/2006EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006EP1717227A1 Substituted indole compounds, their preparation and use in medicaments
11/02/2006EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006EP1717225A1 Bicyclic amide derivatives
11/02/2006EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006EP1716141A1 Benzopyran derivatives, method of production and use thereof
11/02/2006EP1716130A1 Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
11/02/2006EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006EP1715862A1 Kinase inhibitors
11/02/2006EP1395568B1 4-aminopyrimidine derivatives
11/02/2006EP1244446B1 Thrombopoietin mimetics
11/02/2006EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006EP1194144B1 Antibacterial compounds
11/02/2006EP1143959B1 Antifungal activity of dicationic molecules
11/02/2006EP1036063B1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
11/02/2006EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006CA2607473A1 Herbicidally active phenylsulphonyl-urea
11/02/2006CA2605580A1 Benzodioxane and benzodioxolane derivatives and uses thereof
11/02/2006CA2604603A1 Novel cyclic amines
11/01/2006CN1856479A Gamma-secretase inhibitors
11/01/2006CN1856477A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006CN1856308A Excitatory amino acid receptor antagonists
11/01/2006CN1856305A Pyridine derivatives and use thereof as urotensin II antagonists
11/01/2006CN1856249A Pyridyl pyrimidines for use as pesticides
11/01/2006CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/2006
10/31/2006US7129363 Conductive compound, electrode and sensor containing the same, and target molecule detection method using the sensor
10/31/2006US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006US7129260 Isoindolinone kinase inhibitors
10/31/2006US7129253 Compounds
10/31/2006US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots
10/31/2006US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions
10/31/2006US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006US7129228 Heterocyclic analgesic compounds and methods of use thereof
10/31/2006CA2406685C Oxadiazole derivatives having anticancer effects
10/31/2006CA2276455C Phthalazinones
10/31/2006CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006CA2246126C New piperazine compounds
10/31/2006CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/31/2006CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators
10/26/2006WO2006113864A2 Oxindole compounds and their uses as therapeutic agents
10/26/2006WO2006113458A1 Heterocyclic inhibitors of protein arginine methyl transferases
10/26/2006WO2006112549A1 Fused heterocyclic compound
10/26/2006WO2006112479A1 Nitrogen-containing heterocyclic compound
10/26/2006WO2006112464A1 Piperazine-substituted benzothiophenes for treatment of mental disorders
10/26/2006WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators
10/26/2006WO2006085113A3 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
10/26/2006WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006WO2006036941A3 Specific kinase inhibitors
10/26/2006WO2005113534A3 Cxcr1 and cxcr2 chemokine antagonists
10/26/2006WO2005105778A3 4-amino-5-cyanopyrimidine derivatives